A few key topics that were discussed on day 2 of the World Cancer Leaders’ Summit – Union for International Cancer Control (UICC)
“On day 2 of the World Cancer Leaders’ Summit, we continued our discussions on critical topics shaping the future of cancer control. A few key topics were discussed:
-What is the link between cancer and climate change? Experts from the oncology and environmental sciences examined the impact of climate change on cancer but also the contribution of the health sector to environmental pollution.
– We discussed the development and implementation of cancer control in fragile and emergency settings, with a focus on both displaced and host populations.
– Senior government officials underscored the importance of Universal Health Coverage (UHC) as a fundamental right and a key pillar of sustainable development.
– From targeted marketing strategies aimed at young people to resistance and interference in government regulation for tobacco products, panellists dissected the methods employed by tobacco and vaping companies to undermine implementation of the Framework Convention on Tobacco Control (FCTC).
– Experts from the fields of oncology, infectious diseases, and public health shed light on the growing concern of Antimicrobial resistance and its profound implications for cancer management.
– Early intervention and prevention are key to limit the risk of obesity on cancer. The speakers highlighted the sociocultural, policy, environmental, and behavioural factors influencing obesity rates and suggested approaches towards developing tailored responses in countries around the world.
The two days of discussion and debate leave us with valuable insights and a renewed commitment to work beyond the summit.”
Source: Union for International Cancer Control (UICC)/LinkedIn
-
12:46 30/11/23 | BlogJohanna Joyce: the Flashlight method
-
12:31 30/11/23 | InsightJeff Ryckman: Omitting RT in bulky early-stage cHL
-
07:45 30/11/23 | BlogAaron Goodman: Hemoglobin Dissociation Curve! Good stuff
-
12:31 30/11Jeff Ryckman: Omitting RT in bulky early-stage cHL
-
17:28 29/11JeeSuk Chang: A multi-center trial - great efforts from the KROG team
-
17:00 29/11Maite Bourlon: Access to novel drugs for metastatic renal cell carcinoma is an unmet need in the Mexican population
-
23:17 28/11Manni Mohyuddin: Current trials must have observation/surveillance as control arm
-
23:04 28/11Juan P. Alderuccio: Our approach to secondary CNS involvement by aggressive lymphomas
-
17:43 28/11Michele Carbone: The world is full of good, honest, nice people
-
17:24 28/11Jessica Clerc: Celebrating 90 Years of Excellence and Dedication in Cancer Care!
-
17:44 25/11Carlos Pedraz: Congratulations, Dr. Rafael Rosell for the very well deserved 2023 ISLB Lifetime Achievement Award
-
17:10 25/11100 Influential Celebrities in Oncology: The 2023 Edition – Part 4
-
13:34 24/11"Bald for a Cause" initiative - UWC Dilijan College
-
17:34 28/11The International Association of Cancer Registries annual conference - IARC
-
18:05 26/11Submit your abstract by 13 February for ESMO-Breast-24 - ESMO
-
17:58 26/11Lisa A. Lacasse: My sincere gratitude to the ACS CAN team, our incredible volunteers, and supporters for another outstanding year
-
16:47 16/11How social determinants can influence a patient’s ability to stay in treatment - ASCO
-
13:22 16/11SIOP Europe Student Summer School for Paediatric Oncology
-
17:25 29/11NIH Director’s Early Independence Award supports junior scientists to launch independent careers - National Cancer Institute
-
17:07 29/11Santhosh Kumar Devadas: I’m starting a new position as a Professor of Medical Oncology and Chief of Bone Marrow Transplant at Ramaiah Memorial Hospital and Ramaiah Medical College
-
16:48 27/11CRCHD seeks motivated scientists to serve as Program Directors - NCI Disparities
-
16:25 27/11Luisa Basset completed a fruitful nine-year tenure on the CCI board of trustees - Childhood Cancer International
-
18:14 26/11Tristan Knight: Attention hematology / oncology and pediatric hematology / oncology fellows